FDA Approved: TOPAMAX — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TOPAMAX (topiramate) filed by Janssen Pharmaceuticals, Inc., to update/expand the approved labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Migraine

Drugs mentioned

• Topamax (Topiramate)

Snippet

SUPPL AP for TOPAMAX (TOPIRAMATE)